MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Constipation with selected prodromal features increases risk of subsequent Parkinson’s Disease

    E. Brown, S. Goldman, K. Albers, S. Vanden Eeden, C. Tanner (San Francisco, CA, USA)

    Objective: To use the electronic medical record (EMR) to understand the independent and joint effects of constipation and other prodromal features on the risk of…
  • 2019 International Congress

    Non-motor symptoms contribute to the caregiver burden in Progressive Supranuclear Palsy

    ZC. Chen, YM. Liu (Jinan, China)

    Objective: To investigate the clinical features of NMS in PSP patients and analyze the influences on the burden of the caregivers. Background: NMS was wildly…
  • 2019 International Congress

    Bumetanide to treat Parkinson’s disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and subthalamic deep brain stimulation: an open-label pilot study (BumFOG)

    P. Damier, W. Kamel, J. Al Hashel (Kuwait, Kuwait)

    Objective: to investigate the effects of bumetanide in  Parkinson's disease (PD) patients suffering from freezing of gait (FOG) resistant to dopamine replacement therapy and subthalamic…
  • 2019 International Congress

    Striatal dopaminergic regulation of micrographia in parkinsonism

    M. Eklund, J. Joutsa, S. Nuuttila, E. Mäkinen, E. Jaakkola, T. Noponen, T. Ihalainen, M. Koivisto, S. Teperi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To investigate the role of brain dopamine function in writing and drawing micrographia of patients with parkinsonism. Background: Micrographia, an abnormally small or progressively…
  • 2019 International Congress

    Spin turns and step turns in advanced Parkinson’s disease: a new clinical gait sign?

    O. Gavriliuc, S. Paschen, A. Andrusca, C. Schlenstedt, G. Deuschl (Chisinau, Republic of Moldova)

    Objective: To evaluate which approach patients with Parkinson’s disease (PD) choose when they change direction of walk and if L-dopa and subthalamic nucleus deep brain…
  • 2019 International Congress

    Neuropathy in patients treated with LCIG in the Czech and the Slovak Republic

    P. Havránková, J. Klempíř, J. Roth, E. Růžička, M. Baláž, M. Bareš, I. Rektorová, M. Kaiserová, P. Kaňovský, M. Minár, K. Gmitterová, P. Valkovič, M. škorvánek, V. Haň, L. Skička, J. Necpál, M. Grófik, E. Kurča, R. Jech (Praha, Czech Republic)

    Objective: To identify occurrence, severity and clinical factors associated with neuropathy in patients with Parkinson's disease (PD) treated with LCIG (levodopa – carbidopa intestinal gel)…
  • 2019 International Congress

    Availability of levodopa and clinicopathological features of patients with multiple system atrophy

    C. Ishida, K. Komai, K. Takahashi, Y. Motozaki, A. Tagami, S. Shibata, M. Asakawa (Kanazawa, Japan)

    Objective: To investigate the availability of levodopa for pathologically confirmed multiple system atrophy (MSA) patients and determine the clinicopathological features of levodopa responders with MSA.…
  • 2019 International Congress

    Gray matter atrophy in Parkinson’s disease and freezing of gait assessed using surface-based algorithm – results of an open, longitudinal, single-centre study

    P.. Kanovsky, M.. Vastik, K.. Mensikova, P.. Hok, J.. Valosek, P.. Hlustik (Olomouc, Czech Republic)

    Objective: The subsequent open, longitudinal  study was  performed to test whether grey matter (GM) atrophy  and FOG severity changes over time and whether there is…
  • 2019 International Congress

    The impact of HIV on the severity and course of Parkinson’s disease: a clinical case

    A. Kudrevatykh, E. Gracheva, I. Miliukhina (St. Petersburg, Russian Federation)

    Objective: About 12 million people in the world suffer from Parkinson's disease (PD), and 36.9 million suffer from HIV. The proportion of people with HIV…
  • 2019 International Congress

    Modulation of cerebellar and basal ganglia loops affects vestibular processing in Parkinson’s disease

    J. Liao, C. Mcintyre, A. Shaikh (Cleveland, OH, USA)

    Objective: To investigate physiology of impaired balance control in Parkinson’s Disease and its modulation by deep brain stimulation Background: Postural instability leading to falls is…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley